Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
(NYSE: PFE) today announced the decision to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, which was being investigated for chronic weight management
Any questions must be discussed with your healthcare professional before beginning treatment
Exp Hematol 20(5):569-75, 1992
Low levels of Glutathione (GSH) could be one of the major causes of the excessive inflammatory response (inflammatory storm) linked to severe COVID-19 symptoms of the lungs and even indicate that focusing on increasing body GSH could reduce the number of symptomatic patients
US$ 27.41
US$ 27.41
US$ 23.45
US$ 25.00
US$ 28.06
US$ 23.66
US$ 26.08
US$ 20.00
